
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $91.9M | -- | -- | $0.88 | -- |
07/29/2025 | Q2 | $90.3M | -- | -- | $0.83 | -- |
04/28/2025 | Q1 | $79.6M | $81.4M | $0.30 | $0.66 | -$0.36 |
01/27/2025 | Q4 | $64M | $65.1M | $0.78 | $0.70 | $0.08 |
10/28/2024 | Q3 | $63.8M | $62.4M | $0.71 | $0.70 | $0.01 |
07/29/2024 | Q2 | $61.4M | $26.6M | $0.69 | $0.62 | $0.07 |
04/29/2024 | Q1 | $62.9M | $60.8M | $0.64 | $0.64 | -$0.00 |
01/29/2024 | Q4 | $63.1M | $61.2M | $0.73 | $0.67 | $0.06 |
10/30/2023 | Q3 | $63.8M | $62.4M | $0.73 | $0.69 | $0.04 |
07/31/2023 | Q2 | $63.6M | $63.2M | $0.75 | $0.68 | $0.07 |
04/24/2023 | Q1 | -- | $64M | $0.71 | -- | -- |
01/30/2023 | Q4 | -- | $66M | $0.83 | -- | -- |
11/07/2022 | Q3 | -- | $65.8M | $0.83 | -- | -- |
08/09/2022 | Q2 | -- | $64.8M | $0.81 | -- | -- |
04/25/2022 | Q1 | -- | $63.1M | $0.31 | -- | -- |
01/31/2022 | Q4 | -- | $55.7M | $0.73 | -- | -- |
11/09/2021 | Q3 | -- | $56.8M | $0.81 | -- | -- |
07/26/2021 | Q2 | -- | $53.8M | $0.90 | -- | -- |
04/26/2021 | Q1 | -- | $54M | $0.74 | -- | -- |
01/25/2021 | Q4 | -- | $56.8M | $0.79 | -- | -- |
10/26/2020 | Q3 | -- | $51.7M | $0.55 | -- | -- |
07/27/2020 | Q2 | -- | $50.9M | $0.54 | -- | -- |
05/06/2020 | Q1 | -- | $50.3M | $0.47 | -- | -- |
01/27/2020 | Q4 | -- | $50.7M | $0.59 | -- | -- |
10/28/2019 | Q3 | -- | $50.6M | $0.49 | -- | -- |
07/29/2019 | Q2 | -- | $44.2M | $0.61 | -- | -- |
04/29/2019 | Q1 | -- | $45.2M | $0.60 | -- | -- |
01/28/2019 | Q4 | -- | $42.7M | $0.44 | -- | -- |
10/29/2018 | Q3 | -- | $37.5M | $0.55 | -- | -- |
07/30/2018 | Q2 | -- | $36.4M | $0.48 | -- | -- |
04/30/2018 | Q1 | -- | $35.1M | $0.51 | -- | -- |
01/29/2018 | Q4 | -- | $33M | $0.51 | -- | -- |
10/30/2017 | Q3 | -- | $33.2M | $0.42 | -- | -- |
07/31/2017 | Q2 | -- | $32.6M | $0.43 | -- | -- |
04/24/2017 | Q1 | -- | $32.9M | $0.42 | -- | -- |
01/30/2017 | Q4 | -- | $33.2M | $0.44 | -- | -- |
10/31/2016 | Q3 | -- | $32.9M | $0.45 | -- | -- |
07/25/2016 | Q2 | -- | $32.7M | $0.43 | -- | -- |
04/28/2016 | Q1 | -- | $28M | $0.25 | -- | -- |
01/25/2016 | Q4 | -- | $25.9M | $0.39 | -- | -- |
10/26/2015 | Q3 | -- | $26.6M | $0.39 | -- | -- |
German American Bancorp reported $81.4M worth of top line sales in its most recent quarter.
German American Bancorp announced earnings per share of $0.30 which represents a miss of analyst forecast a $0.66 per share.
German American Bancorp reported -- that represents -- per share over the last quarter.
German American Bancorp's earnings are forecast to grow from $2.83 per share to $2.76 per share next year representing an increase of 17.55%.
German American Bancorp's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.